Follow
In silico evaluation of Paxlovid's pharmacometrics for SARS-CoV-2: a multiscale approach. (arXiv:2204.11006v1 [q-bio.QM]) http://arxiv.org/abs/2204.11006
In silico evaluation of Paxlovid's pharmacometrics for SARS-CoV-2: a multiscale approach. (arXiv:2204.11006v1 [q-bio.QM]) http://arxiv.org/abs/2204.11006